Margin of safety is job number one

Bullish equity sentiment at 59.2% was at an eye-watering 40 points above bearish sentiment (19.4%) in last week’s Investors Intelligence Data. Heavily indebted amid high unemployment and low yields, a desperate retail crowd has once more joined long-always managers and funds all-in on equities, gold and cryptocurrencies that have no security of principal, due date or contractually prescribed income payments.  The exodus into the riskiest assets at record high pricing has truly been historic.  Lurching from one capital blow up to another, the financially undisciplined scoff at those who emphasize principal protection and margin of safety.  Hubris comes before the fall.

As economist David Rosenberg recently wrote:

You own bonds in the portfolio to manage your risk, so ignore those folks who tell you to dump your bonds because yields are too low. They are low because, as a price, the bond market is telling you that we are heading into a future of ultra-low expected returns.

There is inflation risk and duration risk in Treasuries, to be sure, but they are unique in their payment safety characteristics. They are the only assets where security and certainty of payment is assured and guaranteed.

The losses from February to March clearly recovered too quickly for financial wisdom to stick–all evidence that the bottom and final liquidation sale are yet to complete.

Komal Sri-Kumar, president and founder at Sri-Kumar Global Strategies, explains why he sees the current environment is better for bonds than gold. He speaks with Bloomberg’s Guy Johnson on “Bloomberg Markets. Here is a direct video link.

Posted in Main Page | Comments Off on Margin of safety is job number one

How mRNA vaccines work

This report was published in September before the November phase three trial results from Pizer/BioNTech and Moderna were announced.  Worthwhile overview.

More than 30 biotech and pharmaceutical companies around the world are racing to develop a safe Covid-19 vaccine. The process is moving quickly with several vaccine candidates entering late-stage trials in a matter of months. Two of the companies developing a vaccine — Pfizer and Moderna — are utilizing a promising new technology called messenger RNA. Watch the video to learn why experts believe this vaccination method could be a game-changer for getting back to normal. Here is a direct video link.

Posted in Main Page | Comments Off on How mRNA vaccines work

Danielle’s bi-weekly market update

Danielle was a guest with Jim Goddard on Talk Digital Network, talking about the world economy and markets. You can listen to an audio clip of the segment here.

Posted in Main Page | Comments Off on Danielle’s bi-weekly market update